|
|
Volumn 350, Issue 2, 2004, Pages 99-101
|
|
Daily Aspirin - Only Half the Answer
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
ALKYLATING AGENT;
AMINOCAPROIC ACID;
VON WILLEBRAND FACTOR;
BLEEDING;
BLOOD CLOTTING;
BLOOD VISCOSITY;
CARDIOVASCULAR RISK;
CHEMOTHERAPY;
CLINICAL FEATURE;
CLINICAL TRIAL;
DISEASE ASSOCIATION;
DRUG EFFICACY;
DRUG SAFETY;
ERYTHROCYTE;
ERYTHROCYTOSIS;
ERYTHROMELALGIA;
HEMATOCRIT;
HEMATOPOIESIS;
HUMAN;
HYPERCOAGULABILITY;
LEUKOCYTE ACTIVATION;
LIVER VEIN THROMBOSIS;
MIGRAINE;
PHLEBOTOMY;
POLYCYTHEMIA VERA;
PRIORITY JOURNAL;
REVIEW;
SHEAR STRESS;
SIDE EFFECT;
THROMBOCYTE ACTIVATION;
THROMBOCYTE AGGREGATION;
THROMBOCYTOSIS;
THROMBOSIS;
ASPIRIN;
HUMANS;
PHLEBOTOMY;
PLATELET AGGREGATION INHIBITORS;
PLATELET COUNT;
POLYCYTHEMIA VERA;
THROMBOSIS;
|
|
EID: 0347988054
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJMp038177 Document Type: Review |
|
Times cited : (16)
|
|
References (0)
|
